Almirall
Manufacturing · Spain · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Ronda General Mitre 151, Barcelona, Cata...Phone Number
+34 932913000Website
www.almirall.comRevenue
$1.3 BillionStock Symbol
ALMIndustry
About Almirall
Almirall Org Chart
Is Almirall your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Almirall had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Almirall has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Almirall is spiking on competitors!
Website visits: Recent activity has been detected on your website
Almirall, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Almirall has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Almirall launches new products
Earning: See what the market has to say on Almirall recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Almirall
Recommended Actions
Reach out to Masked Content who joined Almirall as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Almirall is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Almirall is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Almirall.
Almirall Tech Stack
A closer look at the technologies used by Almirall
Most Recent Scoops
Almirall News & Media
EpimAb Biotherapeutics Announces the First CTA Filing of a FIT-IG® Bispecific Antibody by its License Partner Almirall
SHANGHAI, Feb. 10, 2026 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biopharmaceutical company specializing in the development of novel multispecific antibodies, today announced the achievement of a first CTA Filing by Almirall (www.almirall.com) under the license agreement between the companies completed in 2023.Almirall, S.A. (LBTSF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Almirall, S.A. (LBTSF) 44th Annual J.P.Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target
BARCELONA, Spain and VANCOUVER, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Almirall (BME: ALM), a global biopharmaceutical company focused on medical dermatology, and Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics with generative AI, today announced the expansion of their ongoing AI Drug Discovery collaboration with Almirall’s selection of a second target aimed at dermatological indications.Almiralll, S.A. (LBTSF) Q1 2025 Earnings Call Transcript
Almiralll, S.A. (OTCPK:LBTSF) Q1 2025 Results Conference Call May 12, 2025 4:00 AM ETCompany ParticipantsPablo Divasson - Investor RelationsCarlos Gallardo...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Almirall
Founded in 1943, Almirall is a global biopharmaceutical company focused on medical dermatology. It researches, develops, manufactures, and commercializes prescription treatments for skin diseases such as psoriasis, atopic dermatitis, and actinic keratosis. Headquarters: Barcelona, Spain.... Read More